Market Access News | pharmaphorum

News

Job losses start at federal agencies, including HHS, but initial reports suggest some workers who have been let go are quickly being reinstated.

News

AstraZeneca has become the second pharma group to reach an agreement with the Trump administration on Most Favoured Nation (MFN) drug pricing.

News

The first stage of AstraZeneca's promised $50 billion investment in US facilities is underway as it breaks ground on a facility in Virginia.

News

Possible implications of TrumpRx, the federal direct-to-consumer sales channel, are starting to emerge ahead of its scheduled launch next year.

News

The regulatory authorities in the UK and US have agreed to work more closely together on the regulation of medical technologies and AI.

News

Changes to the threshold used by NICE to measure cost-effectiveness could be on the way as part of a plan that would raise NHS spending on medicines.